These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20707829)

  • 1. Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients.
    Fabroni C; Gori A; Troiano M; Prignano F; Lotti T
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):549-53. PubMed ID: 20707829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to managing patients with nail psoriasis.
    Reich K
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
    Rich P; Griffiths CE; Reich K; Nestle FO; Scher RK; Li S; Xu S; Hsu MC; Guzzo C
    J Am Acad Dermatol; 2008 Feb; 58(2):224-31. PubMed ID: 18083272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients.
    Vitiello M; Tosti A; Abuchar A; Zaiac M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):358-62. PubMed ID: 23330782
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.
    Lin YK; See LC; Chang YC; Huang YH; Chen JL; Tsou TC; Leu YL; Shen YM
    Dermatology; 2011; 223(3):239-43. PubMed ID: 22056841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis.
    Bardazzi F; Antonucci VA; Tengattini V; Odorici G; Balestri R; Patrizi A
    J Dtsch Dermatol Ges; 2013 Nov; 11(11):1065-70. PubMed ID: 24119121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.
    Rigopoulos D; Gregoriou S; Makris M; Ioannides D
    Dermatology; 2011; 223(4):325-9. PubMed ID: 22134046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
    Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
    Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission and time of resolution of nail psoriasis during infliximab therapy.
    Bianchi L; Bergamin A; de Felice C; Capriotti E; Chimenti S
    J Am Acad Dermatol; 2005 Apr; 52(4):736-7. PubMed ID: 15793554
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of biological agents in the treatment of nail psoriasis.
    Zaiac M
    Am J Clin Dermatol; 2010; 11 Suppl 1():27-30. PubMed ID: 20586503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nail psoriasis with TNF-α or IL12/23 inhibitors.
    Jemec GB; Ibler KS
    J Drugs Dermatol; 2012 Aug; 11(8):939-42. PubMed ID: 22859238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacalcitol ointment for the treatment of nail psoriasis.
    Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
    J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
    Hussain W; Coulson I; Owen C
    Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.